Provided by Tiger Trade Technology Pte. Ltd.

Amarin Corp PLC

14.45
-0.2200-1.50%
Post-market: 14.450.00000.00%16:10 EDT
Volume:60.59K
Turnover:870.73K
Market Cap:300.45M
PE:-7.73
High:14.70
Open:14.51
Low:14.16
Close:14.67
52wk High:20.90
52wk Low:7.52
Shares:20.79M
Float Shares:18.76M
Volume Ratio:1.20
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8699
EPS(LYR):-1.8699
ROE:-8.21%
ROA:-1.29%
PB:0.65
PE(LYR):-7.73

Loading ...

Amarin board shrinks to seven directors; Paul Cohen and Oliver O'Connor exit ahead of 2026 annual meeting

Reuters
·
8 hours ago

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Mar 24

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Mar 19

Amarin cites 2026 ACC/AHA dyslipidemia guideline support for icosapent ethyl in statin-treated patients with elevated triglycerides

Reuters
·
Mar 18

Amarin to present new REDUCE-IT subgroup analysis of icosapent ethyl at ACC 2026

Reuters
·
Mar 16

New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

GlobeNewswire
·
Mar 16

Amarin’s European Outlook Hinges on Recordati’s VAZKEPA Execution, Raising Commercial and IP Risk

TIPRANKS
·
Mar 04

Amarin post hoc REDUCE-IT analysis links icosapent ethyl to fewer hospitalizations and fewer days lost to hospitalization and death

Reuters
·
Mar 02

Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology

GlobeNewswire
·
Mar 02

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amarin (AMRN), Ionis Pharmaceuticals (IONS) and Repligen (RGEN)

TIPRANKS
·
Feb 26

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Feb 26

Rpt-Amarin Reports Fourth Quarter and Full Year 2025 Financial Results

THOMSON REUTERS
·
Feb 25

Corrected-Amarin Q4 Revenue (Not 'Product REV') USD 49.2 Million

THOMSON REUTERS
·
Feb 25

Amarin CFO says ‘well positioned’ to deliver on 2026 strategic priorities

TIPRANKS
·
Feb 25

Amarin Q4 net loss narrows to USD 1.2 million (97%)

Reuters
·
Feb 25

Amarin Corp Q4 Adj. EPS $0.01 Beats $(0.56) Estimate, Sales $49.219M Miss $50.619M Estimate

Benzinga
·
Feb 25

Rpt-Amarin Q4 Product Revenue USD 49.2 Million

THOMSON REUTERS
·
Feb 25

Amarin Corporation PLC expected to post breakeven results a share - Earnings Preview

Reuters
·
Feb 23

This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease

GlobeNewswire
·
Feb 23

Amarin Corporation plc to Announce Financial Results and Host Conference Call

Reuters
·
Feb 11